Ethyl 1,2-dimethyl-4-oxo-6-(trifluoromethoxy)-1,2,3,4-tetrahydroquinoline-3-carboxylate, 98%, 1g

(2E)-3-(3,4-dimethoxyphenyl)-N-methoxy-N-methylprop-2-enamide, 95.0%, 10g

Isoquinolin-3-ylmethanamine hydrochloride, 97.0%, 100mg

5-Ethyl-1H-pyrazole-3-carboxylic acid, 95.0%, 250mg

GC capillary column ROTI®Cap-5, 10 m, 0.53 mm, 0.50 µm, 1 Piece(s)

3-Aminopropionitrile Fumarate>98.0%(T)25g

3-Chlorosulfonyl-4-methylbenzoic acid, 95.0%, 25g

1,1,4,4,5,5,8,8-Octamethyl-1,2,3,4,5,6,7,8-octahydroanthracene, 97.0%, 25g

7-[(4-methoxyphenyl)methyl]-5-methyl-1H,4H,5H,6H,7H-pyrazolo[3,4-d]pyrimidine-4,6-dione, 97%, 100mg

5-Chloro-1H-pyrazole-4-carboxylic acid, 95.0%, 10g

3,5-Dinitrobenzoic acid, 95.0%, 100g

2-Amino-3-chloro-5-nitropyridine, 95.0%, 100mg

tert-Butyl 4-(3-bromo-1H-pyrazol-1-yl)piperidine-1-carboxylate, 95.0%, 10g